CAS 920289-29-8

AGG-523

CAS: 920289-29-8

AGG-523 is a molecule that binds to the response element-binding protein (RBP) and inhibits its transcriptional activity. This leads to decreased production of inflammatory cytokines, such as TNF-α and IL-1β, which are responsible for the symptoms of inflammatory bowel disease. AGG-523 has been shown to be safe in humans and can be used to treat bowel diseases. 3-Fluoroindoxyl beta-D-galactopyranoside is an antituberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch-clamp technique on human erythrocytes. This active form is metabolized through a number of metabolic transformations, including hydro

Formula: C₂₈H₂₉FN₂O₄

Purezza: Min. 95%

Peso molecolare: 476.54 g/mol

Ref: 3D-BA178432

AGG-523

CAS: 920289-29-8

AGG-523, an aggrecanase inhibitor, may slow cartilage wear after joint injury by reducing ARG-aggrecan in rats.

Formula: C₂₈H₂₉FN₂O₄

Colore e forma: Solid

Peso molecolare: 476.54

Ref: TM-T68344